Sign in
4

Changes in Ownership

HAEMONETICS CORP Filed Acc 0001127602-24-016164

EVP and General Counsel sold 2,677 shares at an average $95.05 ($254,443)

  • EVP and General Counsel gave up 669 shares (to pay taxes)
  • EVP and General Counsel acquired 4,178 shares (grant or award)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Basil Michelle L · EVP and General Counsel

Table I: Non-derivative

4 lines
Date Transaction Shares Price Value Owned after D/I
2024-05-17 Sale : show line 1 in the form 10b5-1 −1,073 $95.00 $101,935 29,352 D
2024-05-17 Shares withheld for taxes : show line 2 in the form 10b5-1 −669 $95.73 $64,043 28,683 D
2024-05-17 Grant or award : show line 3 in the form 10b5-1 +4,178 32,861 D
2024-05-20 Sale : show line 4 in the form 10b5-1 −1,604 $95.08 $152,508 31,257 D
Open-market sales · 2,677 sh · avg $95.05 · $254,443

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2024-05-17 Grant or award : show line 5 in the form 10b5-1 Non-qualified Stock Option (Right to Buy) +9,183 9,183 D
Loading xslF345X05/form4.xml…